Post hoc analysis of the LANDMARK TAVR trial (596 of 768 patients with severe aortic stenosis): 1-year mortality rose with updated cardiac damage stage, from 0% at stage 0 to 20.4% at stage 4 (AUC 0.739); stage 4 was independently associated with death.
Secondary analysisn = 596
Tobe et al. Cardiac Damage and Clinical Outcomes in Symptomatic Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement